|
Volumn 21, Issue 5, 2010, Pages 466-467
|
New anticoagulants in internal medicine: An update
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANTICOAGULANT AGENT;
DABIGATRAN;
DABIGATRAN ETEXILATE;
WARFARIN;
BLEEDING;
BRAIN HEMORRHAGE;
BRAIN ISCHEMIA;
CARDIAC PATIENT;
CARDIOVASCULAR RISK;
CLINICAL TRIAL;
DRUG DOSE COMPARISON;
DRUG EFFICACY;
DRUG HALF LIFE;
DRUG HYDROLYSIS;
DRUG INDICATION;
DRUG SAFETY;
DYSPEPSIA;
EMBOLISM;
HEART ATRIUM FIBRILLATION;
HIGH RISK PATIENT;
HUMAN;
INTERNAL MEDICINE;
LETTER;
MORTALITY;
OUTCOME ASSESSMENT;
PROTHROMBIN TIME;
STROKE;
TIME TO MAXIMUM PLASMA CONCENTRATION;
VENOUS THROMBOEMBOLISM;
ANTICOAGULANTS;
HUMANS;
INTERNAL MEDICINE;
VENOUS THROMBOEMBOLISM;
|
EID: 77956399434
PISSN: 09536205
EISSN: None
Source Type: Journal
DOI: 10.1016/j.ejim.2010.06.006 Document Type: Letter |
Times cited : (4)
|
References (6)
|